Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,23
KB1,07
PKN98,3198,550,65
Msft499,15499,23-1,55
Nokia5,96,048-0,33
IBM312,56312,81,95
Mercedes-Benz Group AG58,3258,34-0,07
PFE24,8724,881,08
06.11.2025 20:20:32
Indexy online
AD Index online
select
AD Index online
 

  • 06.11.2025 20:14:39
Oppenhemeir (OPY, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
68,08 -0,10 -0,07 655 247
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 06.11.2025
Popis společnosti

Business Summary: Oppenheimer Holdings Inc., through its subsidiaries, is a middle market investment bank and full-service broker-dealer. The Company is engaged in a broad range of activities in the financial services industry, including retail securities brokerage, institutional sales and trading, investment banking (corporate and public finance), equity and fixed income research, market-making, trust services, and investment advisory and asset management services. The Company’s Wealth Management segment provides a comprehensive array of financial services through a network of financial advisors. Its wealth management services include full-service brokerage, wealth planning, and margin lending. Its Capital Markets segment includes investment banking, institutional equities sales, trading, and research, taxable fixed income sales, trading, and research, public finance and municipal trading, as well as the Company's operations in the United Kingdom, Hong Kong and Israel.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Oppenheimer Holdings Inc revenues increased 8% to $741M. Net income increased 44% to $52.3M. Revenues reflect Capital Markets segment increase of 21% to $246.2M, Americas segment increase of 8% to $713.5M, Europe/Middle East segment increase of 8% to $26.1M. Net income benefited from Real estate leases - Interest expense decrease of 6% to $6.1M (expense).



  • Poslední aktualizace: 06.11.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, Executive Director, Member of the Executive BoardJan Moller Mikkelsen65
Chief Financial Officer, Executive Vice President, Member of the Executive BoardScott Smith5108.08.2016
Executive Vice President, Chief Administrative Officer, Member of the Executive BoardLotte Soenderbjerg63
Executive Vice President, Chief Legal Officer, Member of the Executive BoardMichael Jensen54
Executive Vice President, Product Supply and QualityFlemming Jensen64
Executive Vice President, Chief Medical OfficerAimee Shu,48
Executive Vice President, Head of Clinical Development, OncologyStina Singel51
Executive Vice President, Head of Innovation and ResearchKennett Sprogoee46
Executive Vice President, U.S. PresidentDonovan Wu39
Senior Vice President, Head of Finance and Principal Accounting OfficerMads Bodenhoff56